HELICON THERAPEUTICS INC
Advanced composite parts for unmanned systems
- Sector
- Aerospace
- Headquarters
- SAN DIEGO, CA
- Latest Form D
- $50M, Jun 2009
- Total capital
- $50M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $50M
- 1 Form D · last Jun 2009
- 208 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 15 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$50M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Jonathan Gelles, D. Phil.DirectorNamed in SEC Form D filings
- Kenneth DartDirectorNamed in SEC Form D filings
- Kenneth E. Johns, Jr.Executive Officer, DirectorNamed in SEC Form D filings
- Tim Tully, PhD.Executive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 15- PendingTherapeutic PiperazinesUSPTOApplication PCTUS2011052441
- PendingNeurite Outgrowth As An Assay For Memory Enhancing CompoundsUSPTOApplication PCTUS2008088477
- PendingTherapeutic Isoxazole CompoundsUSPTOApplication PCTUS2008074353
Show all 15 patent records
- Therapeutic PiperazinesApplication PCTUS2011052441Pending
- Neurite Outgrowth As An Assay For Memory Enhancing CompoundsApplication PCTUS2008088477Pending
- Therapeutic Isoxazole CompoundsApplication PCTUS2008074353Pending
- Therapeutic Pyrazoloquinoline Urea DerivativesApplication PCTUS2008066205Pending
- Therapeutic Pyrazolonaphthyridine DerivativesApplication PCTUS2008066211Pending
- Therapeutic Pyrazoloquinoline DerivativesApplication PCTUS2008066201Pending
- Methods Of Treating Cognitive Disorders By Inhibition Of GPR12Application PCTUS2008063804Pending
- Methods Of Identifying Genes Involved In Memory Formation Using Small Interfering Rna(sirna)Application PCTUS2008063806Pending
- Method Of Modulating Neurite Outgrowth By The Use Of A GALANIN-3 Receptor AntagonistApplication PCTUS2007072166Pending
- Phosphodiesterase 4 Inhibitors For Cognitive And Motor RehabilitationApplication PCTUS2007069279Pending
- Therapeutic CompoundsApplication PCTUS2007005157Pending
- Therapeutic PiperazinesApplication PCTUS2007005159Pending
- Indolone Compounds Useful To Treat Cognitive ImpairmentApplication PCTUS2006046826Pending
- Screening Methods For Cognitive EnhancersApplication PCTUS2003025942Pending
- Altering Memory By Affecting Staufen FunctionApplication PCTUS2003020125Pending
Related companies, and why
- SAKINAH SALON, LLCSimilar federal contract value in Aerospace · null in contracts
- VERAPHOTONICS INCSimilar federal contract value in Aerospace · null in contracts
- OVERAIR, INC.Similar federal contract value in Aerospace · null in contracts
- Bond Technologies, Inc.Similar federal contract value in Aerospace · null in contracts
- OPEN SOURCE INSTRUMENTS INCSimilar federal contract value in Aerospace · null in contracts
- STRATOS AIRCRAFT, INC.Similar federal contract value in Aerospace · null in contracts
Regulatory activity · Aerospace
- Nondiscrimination in Federally Assisted Programs of NASA-Effectuation of Title VI of the Civil Rights Act of 1964National Aeronautics and Space Administration
- Special Conditions: AMAC Aerospace, The Boeing Company Model 747- 8 Airplane; Side-Facing SeatsFederal Aviation Administration
- Standard Instrument Approach Procedures, and Takeoff Minimums and Obstacle Departure Procedures; Miscellaneous AmendmentsFederal Aviation Administration
- Operating Limitations at John F. Kennedy International AirportFederal Aviation Administration
- Operating Limitations at New York LaGuardia AirportFederal Aviation Administration
- Special Conditions: Honeywell Aerospace US LLC, Dassault Aviation Model Falcon 900EX Airplane; Electronic System Security Protection From Unauthorized External AccessFederal Aviation Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .